Prospective Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Jan 28, 2021; 27(4): 358-370
Published online Jan 28, 2021. doi: 10.3748/wjg.v27.i4.358
Table 1 Clinical and procedural characteristics of the patients
Patients
n = 47
Age (yr, mean ± SD)61 ± 16.5
Male23 (48.9%)
Stone size (mm)14 (14-15)
Multiple CBD stones36 (76.6%)
Diameter of CBD (mm)15 (12-18)
Gallbladder stones21 (44.7%)
Previous cholecystectomy24 (51.1%)
Periampullary diverticulum15 (31.9%)
Total bilirubin (µmol/L)71.1 (64.9-107.9)
Comorbidities
Coronary disease3 (6.4%)
Hypertension14 (29.8%)
Diabetes2 (4.3%)
Liver cirrhosis3 (2.1%)
Portal hypertension1 (6.4%)
ENBD40 (85.1%)
Procedure time, min (mean ± SD)40.3 ± 15.4
Stone texture
Hard stones16 (34.0%)
Soft stones31 (66.0%)
Stone compositions
Cholesterol-based stones17 (36.2%)
Pigment-based stones30 (63.8%)
Procedure-related adverse events
Cholangitis4 (8.5%)
Oozing2 (4.3%)
Pancreatitis4 (8.5%)
Cholecystitis1 (2.1%)
Perforation0
Death0